Furthermore, the activation of the p-p38/CK2 complex was reported to cause a downregulation of ER-α transcription, expression and thus activity (De Amicis et al. 2013), while CK2 inhibition was recently correlated with an increased ERα expression in breast cancer patients (Williams et al. 2015). The gene discussed is ESR1; the disease is breast carcinoma.